Investor group BPGbio acquires company’s AI platform, built with $400M in investment, its drug and diagnostic pipelines By Alex Philippidis – February 8, 2023 After investing around $400 million to develop its artificial intelligence (AI)-based platform and the company formed to commercialize it, Berg has placed its drug and diagnostic pipelines in the hands of an investor…

By Rowan Walrath  –  Life Sciences Reporter, Boston Business Journal Feb 6, 2023 Updated Feb 7, 2023, 10:02am EST – Framingham bioanalytics firm Berg Health LLC has been acquired by BPGbio, a new company funded by a group of investors led by private equity manager Daniel Elliott. Not much is slated change initially. BPG is retaining all of Berg’s employees,…

FRAMINGHAM, Mass., Nov. 8, 2021 /PRNewswire/ — BERG, the clinical stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments, today announced their participation at the Society for Neuroscience (SfN) Annual Meeting from November 8-11, 2021. At the event, the company will highlight their ongoing research into interventions…

FRAMINGHAM, Mass., Sept. 16, 2021 /PRNewswire/ — BERG, a clinical-stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments, today announced its participation at the European Society for Medical Oncology (ESMO) 2021 Congress, from September 16-21, 2021. At the event, the company will unveil its most recent medical…

FRAMINGHAM, Mass., July 29, 2021 /PRNewswire/ — BERG, a clinical-stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments and diagnostics, today announced the publication of a new study, entitled “Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia” in Scientific Reports….

FRAMINGHAM, Mass., July 14, 2021 /PRNewswire/ — BERG, a clinical-stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments, will present two poster presentations at the Society for Neuro-Oncology: Basic and Translational Omics of Brain Tumors and Their Microenvironment Conference, on July 15th and 16th, 2021. The first…